Contemporary thoughts on the treatment of irritable bowel syndrome.
Giaquinta
Diane
D
D002243:Carbolines / Q000009:adverse effects / Q000627:therapeutic use*; D003109:Colonic Diseases, Functional / Q000175:diagnosis / Q000188:drug therapy*; D017277:Drug Approval / Q000331:legislation & jurisprudence; D005765:Gastrointestinal Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D014481:United States; D014486:United States Food and Drug Administration
D002243:Carbolines; D005765:Gastrointestinal Agents; C090840:alosetron